Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Krisztina Hagymási"'
Autor:
Jakub Hoferica, Ruben Zsolt Borbély, Ali Nedjati Aghdam, Eszter Ágnes Szalai, Ádám Zolcsák, Dániel Sándor Veres, Krisztina Hagymási, Bálint Erőss, Péter Hegyi, Peter Bánovčin, Péter Jenő Hegyi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Chronic liver diseases (CLD) affect 1.5 billion patients worldwide, with dramatically increasing incidence in recent decades. It has been hypothesized that the chronic hyperinflammation associated with CLD may increase the risk of a more sev
Externí odkaz:
https://doaj.org/article/37f33251e7eb48e291745f8acf9bf8af
Autor:
Zsolt Szakács, Nelli Farkas, Judit Bajor, Nándor Faluhelyi, Krisztina Hagymási, Zsófia Vereczkei, Míra Zsófia Peresztegi, Klára Lemes, Sarolta Dakó, Eszter Dakó, Szilvia Lada, Gábor Szekeres, Gyula Pásztor, Gabriella Pár, Emese Mezősi
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Introduction Coeliac disease (CD) affects 1% of the population worldwide. The only available evidence-based treatment is a strict gluten-free diet (GFD), which can readily lead to weight gain and unfavourable metabolic changes (eg, dyslipidaemia, fat
Externí odkaz:
https://doaj.org/article/c9a7b09be63f4d01948fb30beddda9bd
Autor:
Diana-Elena Floria, Mahmoud Obeidat, Sarolta Beáta Kávási, Brigitta Teutsch, Dániel Sándor Veres, Krisztina Hagymási, Péter Hegyi, Vasile-Liviu Drug, Bálint Erőss
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The Montreal consensus recognizes chronic cough as an extra-esophageal manifestation of gastroesophageal reflux disease. We performed a meta-analysis to assess the effects of acid-suppressive medications in adults with non-specific chronic c
Externí odkaz:
https://doaj.org/article/949623e34e1d4a1ab553f9e44571c7aa
Autor:
Edina Tari, Endre Botond Gagyi, Anett Rancz, Dániel Sándor Veres, Szilárd Váncsa, Péter Jenő Hegyi, Krisztina Hagymási, Péter Hegyi, Bálint Erőss
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Endoscopic Retrograde Cholangiopancreatography (ERCP) is the primary therapeutic procedure for pancreaticobiliary disorders, and studies highlighted the impact of papilla anatomy on its efficacy and safety. Our objective was to quantify the
Externí odkaz:
https://doaj.org/article/87682414ce004d00927b9b4a070a0f25
Autor:
Anna Egresi, Anna Blázovics, Gabriella Lengyel, Adrienn Gréta Tóth, Barbara Csongrády, Zsuzsanna Jakab, Krisztina Hagymási
Publikováno v:
Diagnostics, Vol 14, Iss 17, p 1945 (2024)
Hepatic fibrosis with various origins can be estimated non-invasively by using certain biomarkers and imaging-based measurements. The aim of our study was to examine redox homeostasis biomarkers and liver stiffness measurements for the assessment of
Externí odkaz:
https://doaj.org/article/b5f118940c6a4713ac99c2574eb49a11
Autor:
Pál Novák Kaposi, Zita Zsombor, Aladár D. Rónaszéki, Bettina K. Budai, Barbara Csongrády, Róbert Stollmayer, Ildikó Kalina, Gabriella Győri, Viktor Bérczi, Klára Werling, Pál Maurovich-Horvat, Anikó Folhoffer, Krisztina Hagymási
Publikováno v:
Diagnostics, Vol 13, Iss 21, p 3353 (2023)
We aimed to develop a non-linear regression model that could predict the fat fraction of the liver (UEFF), similar to magnetic resonance imaging proton density fat fraction (MRI-PDFF), based on quantitative ultrasound (QUS) parameters. We measured an
Externí odkaz:
https://doaj.org/article/e009ad8577794582b13a2cc867bc496f
Autor:
Bálint Drácz, Veronika Müller, István Takács, Krisztina Hagymási, Elek Dinya, Pál Miheller, Attila Szijártó, Klára Werling
Publikováno v:
Biomedicines, Vol 11, Iss 6, p 1541 (2023)
Hypocalcemia is a common condition in liver cirrhosis and is associated with the severity of SARS-CoV-2 infection. However, there is a lack of data demonstrating the prognostic value of hypocalcemia in COVID-19 patients with cirrhosis. This study aim
Externí odkaz:
https://doaj.org/article/4595e89ea62c4b7ea0cfee1384138c87
Autor:
Zita Zsombor, Aladár D. Rónaszéki, Barbara Csongrády, Róbert Stollmayer, Bettina K. Budai, Anikó Folhoffer, Ildikó Kalina, Gabriella Győri, Viktor Bérczi, Pál Maurovich-Horvat, Krisztina Hagymási, Pál Novák Kaposi
Publikováno v:
Medicina, Vol 59, Iss 3, p 469 (2023)
Background and Objectives: This study aims to evaluate artificial intelligence-calculated hepatorenal index (AI-HRI) as a diagnostic method for hepatic steatosis. Materials and Methods: We prospectively enrolled 102 patients with clinically suspected
Externí odkaz:
https://doaj.org/article/88c03b965180467599fc868d39736254
Autor:
Bálint Drácz, Veronika Müller, István Takács, Krisztina Hagymási, Elek Dinya, Pál Miheller, Attila Szijártó, Klára Werling
Publikováno v:
Vaccines, Vol 11, Iss 1, p 50 (2022)
Patients with cirrhosis are vulnerable to hepatic decompensation events and death following COVID-19 infection. Therefore, primary vaccination with COVID-19 vaccines is fundamental to reducing the risk of COVID-19 related deaths in patients with cirr
Externí odkaz:
https://doaj.org/article/e7a85d40365043739d020160caef7e05
Autor:
Bálint Drácz, Diána Czompa, Katalin Müllner, Krisztina Hagymási, Pál Miheller, Hajnal Székely, Veronika Papp, Miklós Horváth, István Hritz, Attila Szijártó, Klára Werling
Publikováno v:
Viruses, Vol 14, Iss 11, p 2360 (2022)
Liver damage in COVID-19 patients was documented as increased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels or an elevated AST/ALT ratio, known as the De Ritis ratio. However, the prognostic value of the elevated De Ritis
Externí odkaz:
https://doaj.org/article/d096c9705775468f956708a0ee4e20c2